Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Liver Transpl. 2015 Feb;21(2):187–194. doi: 10.1002/lt.24042

Table 4.

Univariable and multivariable subhazard ratios (SHRs) and 95% confidence intervals (95% CI) for risk of post-transplant HCC recurrence with the Fine and Gray competing risks regression model.

Univariable Multivariable*
Donor characteristics SHR 95% CI p SHR 95% CI p
Age >=60 (versus <60) 1.66 1.28–2.14 <0.001 1.70 1.31–2.20 <0.001
Ethnicity
  White 1
  Black 1.24 0.93–1.66 0.14
  Hispanic/Latino 1.24 0.91–1.70 0.16
  Asian 0.88 0.43–1.79 0.72
  Other/Multi-race 1.64 0.62–4.36 0.32
DCD 1.14 0.71–1.80 0.54
Partial or split liver (versus whole) 1.61 0.88–2.91 0.12
Cause of death
  Anoxia 1
  Other 1.26 0.64–2.48 0.50
  Stroke 1.29 0.94–1.76 0.11
  Head trauma 1.02 0.73–1.42 0.91
Live donor (versus cadaveric) 0.96 0.30–3.04 0.95
Non-local organ sharing (versus local) 1.45 1.13–1.85 0.003 1.42 1.09–1.84 0.009
HBV core positive 0.67 0.40–1.13 0.13
CDC high risk donor 1.08 0.75–1.55 0.69
HCV positive 0.77 0.40–1.49 0.43
BMI
  Underweight (BMI <18.5) 1
  Normal (BMI 18.5–24.9) 1.28 0.63–2.62 0.49
  Overweight (BMI 25.0–29.9) 1.25 0.61–2.56 0.54
  Obese (BMI >30) 1.31 0.64–2.69 0.46
Donor height (per cm increase) 0.996 0.99–1.01 0.47
CIT (per hour increase) 0.997 0.95–1.04 0.89
*

Adjusted for wait time, tumor volume and size, ablative therapy, AFP>500 ng/mL and diagnosis as well as center clustering.

HHS Vulnerability Disclosure